Corrigendum to “Prognostic and predictive value of CA 19-9 in locally advanced pancreatic cancer treated with multiagent induction chemotherapy: results from a prospective, multicenter phase II trial (NEOLAP-AIO-PAK-0113)”: [ESMO Open 7 (2024) 100552] (ESMO Open (2022) 7(4), (S2059702922001806), (10.1016/j.esmoop.2022.100552))

German Pancreatic Cancer Group (AIO-PAK) and NEOLAP investigators

Research output: Contribution to journalComment/debate

Abstract

The authors regret that in the original publication the affiliation of Dr Algül was incorrectly given. The correct affiliation is now given above. The authors would like to apologise for any inconvenience caused.

Original languageEnglish
Article number103463
JournalESMO Open
Volume9
Issue number5
DOIs
StatePublished - May 2024
Externally publishedYes

Fingerprint

Dive into the research topics of 'Corrigendum to “Prognostic and predictive value of CA 19-9 in locally advanced pancreatic cancer treated with multiagent induction chemotherapy: results from a prospective, multicenter phase II trial (NEOLAP-AIO-PAK-0113)”: [ESMO Open 7 (2024) 100552] (ESMO Open (2022) 7(4), (S2059702922001806), (10.1016/j.esmoop.2022.100552))'. Together they form a unique fingerprint.

Cite this